Skip to content

Preoperative Prediction Model of Pathological Outcomes (Mesorectum Quality and Positive Circumferential Resection Margin) in Patients With Mid-low Rectal Cancer

Preoperative Prediction Model of Pathological Outcomes (Mesorectum Quality and Positive Circumferential Resection Margin) in Patients With Mid-low Rectal Cancer

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03107650
Acronym
PREMARE
Enrollment
323
Registered
2017-04-11
Start date
2018-01-01
Completion date
2020-07-31
Last updated
2021-09-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal Cancer

Brief summary

Elaboration of a preoperative prediction model of the quality of the mesorectum and the involvement of the circumferential margin in patients with mid-low rectal cancer who undergo laparoscopic anterior rectal resection. In a second phase the investigators will study the utility of the prediction model in classifying patients with high risk of suboptimal quality of mesorectum and/or positive circumferential margin. Patients with high preoperative risk will undergo a transanal total mesorectal excision and patients with low risk a laparoscopic transabdominal mesorectal excision. The investigators finally will compare pathological outcomes ( quality of mesorectum and circumferential margin), survival and recurrence between the two groups.

Interventions

PROCEDURETransanal total mesorectal excision of rectal cancer

To perform a total mesorectal excision through a transanal approach

Sponsors

Pere Planellas Giné
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Patients directed to laparoscopic anterior rectal resection through a transabdominal or a transanal approach. * Age ≥ 18 years * Histology of adenocarcinoma or adenoma * With or without neoadjuvant chemoradiotherapy * TNM classification: T2 or T3, any N stage or M stage * Intention of resection R0

Exclusion criteria

* TNM classification: T1 or T4. * Complicated rectal cancer or emergency surgery. * Previous major colorectal surgery

Design outcomes

Primary

MeasureTime frameDescription
Evaluation of the quality of mesorectum in the rectal specimen according to international consensus (goog quality, moderate quality and poor quality)30 daysEvaluation of the quality of mesorectum as optimal or suboptimal (international consensus defines three grades of resection: Group 1: including mesorectal resection, good quality Group 2: intramesorectal resection: moderate quality Group 3: resection in the muscularis propria, poor quality). Investigators will group patients into two groups: optimal mesorectum (group 1) and suboptimal mesorectum (group 2-3).
Evaluation of the circumferential margin status in the rectal specimen according international consensus (positive margin if tumor ≤ 1mm from circumferential margin)30 daysEvaluation of the circumferential margin status (positive or negative) in the rectal specimen according international consensus (positive margin if tumor ≤ 1mm from circumferential margin)

Secondary

MeasureTime frameDescription
Recurrence2 yearsRate of tumor recurrence
Survival2 yearsRate of survival

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 25, 2026